However, no responses were observed in T-ALL patients, and the shared expression of CD52 among normal and malignant T-lymphocytes, expose patients to dangerous effects of lymphopenia, such as reactivation of cytomegalovirus, herpes simplex, or herpes zoster-latent infections [42]. Here, CD52 is linked to lymphopenia.